Literature DB >> 15055820

Cardiac malignant tumor as a rare cause of acute myocardial infarction.

Marek Orban1, Petr Tousek, Ingrid Becker, Norbert Augustin, Christian Firschke.   

Abstract

Acute myocardial infarction is predominantly caused by coronary artery atherosclerotic plaque rupture and subsequent occlusive thrombus formation. The recognition of less common causes of acute myocardial infarction is important because they may require a different treatment strategy. We report a patient with acute myocardial infarction without any angiographic evidence of coronary atherosclerosis and a left atrial mass detected on echocardiography. Therefore, coronary embolism from intracardiac thrombus or tumor was suspected. No additional manifestations of a potential tumor were found on thoracic, abdominal and cranial computed tomography. During subsequent cardiac surgery, a large tumor could be in toto resected and was diagnosed as a highly malignant leiomyosarcoma on histopathological evaluation.

Entities:  

Mesh:

Year:  2004        PMID: 15055820     DOI: 10.1023/b:caim.0000013161.51607.cd

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  16 in total

1.  Primary cardiac leiomyosarcomas.

Authors:  M J Antunes; K M Vanderdonck; C M Andrade; L S Rebelo
Journal:  Ann Thorac Surg       Date:  1991-06       Impact factor: 4.330

Review 2.  Primary cardiac leiomyosarcoma: seven-year survival with combined surgical and adjuvant therapy.

Authors:  R Pessotto; G Silvestre; G B Luciani; M Anselmi; F Pasini; F Santini; A Mazzucco
Journal:  Int J Cardiol       Date:  1997-06-27       Impact factor: 4.164

3.  Primary cardiac leiomyosarcoma: imaging with 2-D echocardiography, electron beam CT and 1.5-Tesla MR.

Authors:  F L Lo; Y H Chou; C M Tiu; G Y Lan; J H Hwang; M S Chern; M M Teng
Journal:  Eur J Radiol       Date:  1998-03       Impact factor: 3.528

Review 4.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.

Authors:  M J Davies; A C Thomas
Journal:  Br Heart J       Date:  1985-04

5.  Atrial transplantation for recurrent cardiac sarcoma.

Authors:  S C Stoica; I M Mitchell; J Foreman; C J Hunt; J Wallwork; S R Large
Journal:  J Heart Lung Transplant       Date:  2001-11       Impact factor: 10.247

Review 6.  Cardiac myxomas.

Authors:  K Reynen
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi.

Authors:  M J Davies; N Woolf; W B Robertson
Journal:  Br Heart J       Date:  1976-07

8.  Myocardial infarction without atherosclerosis.

Authors:  M D Cheitlin; H A McAllister; C M de Castro
Journal:  JAMA       Date:  1975-03-03       Impact factor: 56.272

9.  Recurrent left-sided heart leiomyosarcoma: should heart transplantation be legitimate?

Authors:  G Babatasi; M Massetti; D Agostini; F Galateau; E Saloux; P Nataf; G Grollier; A Khayat
Journal:  J Heart Lung Transplant       Date:  1998-11       Impact factor: 10.247

10.  Frequency of primary tumors of the heart.

Authors:  K Reynen
Journal:  Am J Cardiol       Date:  1996-01-01       Impact factor: 2.778

View more
  3 in total

1.  Papillary fibroelastoma of mitral papillary chordae in a young patient.

Authors:  Rifat Eralp Ulusoy; Fethi Kilicaslan; Ata Kirilmaz; Ejder Kardesoglu; Bekir Sitki Cebeci; Mehmet Dincturk; Ahmet Turan Yilmaz
Journal:  Int J Cardiovasc Imaging       Date:  2006-05-05       Impact factor: 2.357

Review 2.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

Review 3.  Common Vascular Toxicities of Cancer Therapies.

Authors:  Joerg Herrmann
Journal:  Cardiol Clin       Date:  2019-08-26       Impact factor: 2.213

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.